IBB News and Press, iShares Biotechnology ETF From 11/01/25

2025-11-01 03:00:00 ET Innovation remains one of the most persistent drivers of long-term growth – reshaping industries, creating new markets, and sustaining momentum through economic cycles. Yet, identifying trends alone is no longer sufficient. Investors must recognize how them...

2025-10-26 08:15:00 ET Let me start with a quote from Herman Melville's Moby Dick or, The Whale. To produce a mighty book, you must choose a mighty theme. No great and enduring volume can ever be written on the flea, though many there be who have tried it. Read the ful...

2025-10-21 08:52:00 ET With the Fed walking a policy tightrope, investors should resist being complacent about risks and kicking the can down the road. There are opportunities across asset classes for those willing to be selective and carry a dose of caution as they assemble investmen...

2025-10-18 02:30:00 ET By Zain Vawda Week in review Another week has passed by, and the US government shutdown continues. Despite this, the week was still full of volatility as markets grappled with the ongoing US-China stalemate as well as concerns around the US banking sec...

2025-10-14 09:35:57 ET The Health Care Select Sector SPDR® Fund ETF (NYSEARCA: XLV ), which tracks the health care sector, and holds a weightage of 12.12% in the S&P 500 index, rise 3.18% so far this year, compared to 13.14% rise in the broader benchmark index ( SP500 ).......

2025-10-13 09:35:15 ET The S&P 500 Healthcare sector ( XLV ) saw a slight increase in average short interest in September, rising to 1.91% from 1.89% the month prior. Moderna ( MRNA ) remains the most heavily shorted stock within this sector.... Read the full article on Se...

2025-10-10 06:30:00 ET While the threat of tariffs and drug pricing pressures have weighed on the outlook for healthcare stocks recently, some parts of the sector are beginning to stage a recovery. Ram Sampath, VP, Portfolio Research with TD Asset Management, joins MoneyTalk to discuss why ...

2025-10-07 12:05:00 ET By Diederik Stadig What does the Pfizer-Trump deal cover? The deal between the Trump Administration and Pfizer (PFE) provides clarity about the near-term future of the US patent-protected pharmaceutical sector after months of (tariff) uncertainty. ...

2025-10-06 14:50:00 ET By Geoff Bysshe Confusion Rewards Bulls, Not Bears As we head into the fourth quarter of what has been a year marked by historical uncertainty, the chart below shows one measure of it based on a survey of small businesses. There isn’t any sign t...

2025-10-06 13:29:00 ET On September 17 , the Fed began cutting interest rates again, which historically preceded Big Pharma's increased activity in the M&A space.... Read the full article on Seeking Alpha For further details see: My Top 5 Biotech Stocks Big Pharm...